Skip to main content
Top
Published in: Supportive Care in Cancer 12/2021

01-12-2021 | Hematologic Cancer | Original Article

Recommendations for supportive care and best supportive care in NCCN clinical practice guidelines for treatment of cancer: Differences between solid tumor and hematologic malignancy guidelines

Authors: Li Mo, Diana L. Urbauer, Eduardo Bruera, David Hui

Published in: Supportive Care in Cancer | Issue 12/2021

Login to get access

Abstract

Purpose

It is unclear how NCCN guidelines recommend “supportive care” and “best supportive care” in oncology practice. We examined the usage of “supportive care” and “best supportive care” in NCCN guidelines and compared between solid tumor and hematologic malignancy guidelines.

Methods

We reviewed all updated NCCN Guidelines for Treatment of Cancer in October 2019. We documented the frequency of occurrence, definition, and timing of introduction of each term. We compared between solid tumor and hematologic malignancy guidelines.

Results

We identified a total of 37 solid tumor and 16 hematologic guidelines. Thirty-seven (70%) guidelines mentioned “supportive care” and 36 (68%) mentioned “best supportive care.” Hematologic guidelines were significantly more likely than solid tumor guidelines to use the term “supportive care” (median occurrence 19 vs. 2; P = 0.001) and to describe “supportive care” as management of cancer-related complications (N = 11/15, 73% vs. N = 2/22, 9%; P < 0.001). Domains of specialist palliative care were infrequently mentioned (N = 10/37, 27%). In contrast, solid tumor guidelines were significantly more likely than hematologic guidelines to mention “best supportive care” (median occurrence 6 vs. 0; P = 0.016). This term was rarely defined and mostly used in the advanced disease setting.

Conclusion

“Supportive care” and “best supportive care” were frequently used in NCCN guidelines, with significant variations in usage between solid tumor and hematologic oncologists. “Supportive care” was mostly limited to management of cancer-related complications and treatment adverse effects in NCCN guidelines, highlighting the need to go beyond the traditional biomedical model to more a patient-centered care model with greater integration of palliative care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends–an update. Cancer Epidemiol Biomarkers Prev 25:16–27CrossRef Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends–an update. Cancer Epidemiol Biomarkers Prev 25:16–27CrossRef
2.
go back to reference Shah-Manek B, Wong W, Ravelo A, DiBonaventura M (2018) Oncologists’ perceptions of drug affordability using NCCN evidence blocks: results from a national survey. J Manag Care Spec Pharm 24:565–571PubMed Shah-Manek B, Wong W, Ravelo A, DiBonaventura M (2018) Oncologists’ perceptions of drug affordability using NCCN evidence blocks: results from a national survey. J Manag Care Spec Pharm 24:565–571PubMed
3.
go back to reference Ernecoff NC, Check D, Bannon M et al (2020) Comparing specialty and primary palliative care interventions: analysis of a systematic review. J Palliat Med 23:389–396CrossRef Ernecoff NC, Check D, Bannon M et al (2020) Comparing specialty and primary palliative care interventions: analysis of a systematic review. J Palliat Med 23:389–396CrossRef
5.
go back to reference Hui D, De La Cruz M, Mori M et al (2013) Concepts and definitions for “supportive care”, “best supportive care”, “palliative care”, and “hospice care” in the published literature, dictionaries, and textbooks. Support Care Cancer 21:659–685CrossRef Hui D, De La Cruz M, Mori M et al (2013) Concepts and definitions for “supportive care”, “best supportive care”, “palliative care”, and “hospice care” in the published literature, dictionaries, and textbooks. Support Care Cancer 21:659–685CrossRef
6.
go back to reference Lee RT, Ramchandran K, Sanft T, Von Roenn J (2015) Implementation of supportive care and best supportive care interventions in clinical trials enrolling patients with cancerdagger. Ann Oncol 26:1838–1845CrossRef Lee RT, Ramchandran K, Sanft T, Von Roenn J (2015) Implementation of supportive care and best supportive care interventions in clinical trials enrolling patients with cancerdagger. Ann Oncol 26:1838–1845CrossRef
7.
go back to reference Hui D (2014) Definition of supportive care: does the semantic matter? Curr Opin Oncol 26:372–379CrossRef Hui D (2014) Definition of supportive care: does the semantic matter? Curr Opin Oncol 26:372–379CrossRef
8.
go back to reference Cellerino R, Tummarello D, Guidi F, Isidori P, Raspugli M, Biscottini B, Fatati G (1991) A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer. J Clin Oncol 9:1453–1461CrossRef Cellerino R, Tummarello D, Guidi F, Isidori P, Raspugli M, Biscottini B, Fatati G (1991) A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer. J Clin Oncol 9:1453–1461CrossRef
9.
go back to reference Jack B, Boland A, Dickson R, Stevenson J, McLeod C (2010) Best supportive care in lung cancer trials is inadequately described: a systematic review. Eur J Cancer Care (Engl) 19:293–301CrossRef Jack B, Boland A, Dickson R, Stevenson J, McLeod C (2010) Best supportive care in lung cancer trials is inadequately described: a systematic review. Eur J Cancer Care (Engl) 19:293–301CrossRef
10.
go back to reference Cherny N (2011) Best supportive care: a euphemism for no care or a standard of good care? Semin Oncol 38:351–357CrossRef Cherny N (2011) Best supportive care: a euphemism for no care or a standard of good care? Semin Oncol 38:351–357CrossRef
11.
go back to reference Sanz Rubiales A, Sanchez-Gutierrez ME, Flores Perez LA, Del Valle Rivero ML (2020) How is best supportive care provided in clinical trials for patients with advanced cancer? A review of registered protocols of clinical trials. Curr Oncol 27:e100–e105CrossRef Sanz Rubiales A, Sanchez-Gutierrez ME, Flores Perez LA, Del Valle Rivero ML (2020) How is best supportive care provided in clinical trials for patients with advanced cancer? A review of registered protocols of clinical trials. Curr Oncol 27:e100–e105CrossRef
12.
go back to reference Paz-Ares L, de Marinis F, Dediu M et al (2012) Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial. Lancet Oncol 13:247–255CrossRef Paz-Ares L, de Marinis F, Dediu M et al (2012) Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial. Lancet Oncol 13:247–255CrossRef
13.
go back to reference Kang JH, Lee SI, Lim DH et al (2012) Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone. J Clin Oncol 30:1513–1518CrossRef Kang JH, Lee SI, Lim DH et al (2012) Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone. J Clin Oncol 30:1513–1518CrossRef
14.
go back to reference Mo L, Urbauer DL, Bruera E, Hui D (2021) Recommendations for palliative and hospice care in NCCN guidelines for treatment of cancer. Oncologist 26:77–83CrossRef Mo L, Urbauer DL, Bruera E, Hui D (2021) Recommendations for palliative and hospice care in NCCN guidelines for treatment of cancer. Oncologist 26:77–83CrossRef
15.
go back to reference Hui D, Hannon BL, Zimmermann C, Bruera E (2018) Improving patient and caregiver outcomes in oncology: team-based, timely, and targeted palliative care. CA Cancer J Clin 68:356–376CrossRef Hui D, Hannon BL, Zimmermann C, Bruera E (2018) Improving patient and caregiver outcomes in oncology: team-based, timely, and targeted palliative care. CA Cancer J Clin 68:356–376CrossRef
16.
go back to reference Brudno JN, Kochenderfer JN (2019) Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management. Blood Rev 34:45–55CrossRef Brudno JN, Kochenderfer JN (2019) Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management. Blood Rev 34:45–55CrossRef
17.
go back to reference Fu JB, Tennison JM, Rutzen-Lopez IM, Silver JK, Morishita S, Dibaj SS, Bruera E (2018) Bleeding frequency and characteristics among hematologic malignancy inpatient rehabilitation patients with severe thrombocytopenia. Support Care Cancer 26:3135–3141CrossRef Fu JB, Tennison JM, Rutzen-Lopez IM, Silver JK, Morishita S, Dibaj SS, Bruera E (2018) Bleeding frequency and characteristics among hematologic malignancy inpatient rehabilitation patients with severe thrombocytopenia. Support Care Cancer 26:3135–3141CrossRef
18.
go back to reference Fontana L, Strasfeld L (2019) Respiratory virus infections of the stem cell transplant recipient and the hematologic malignancy patient. Infect Dis Clin North Am 33:523–544CrossRef Fontana L, Strasfeld L (2019) Respiratory virus infections of the stem cell transplant recipient and the hematologic malignancy patient. Infect Dis Clin North Am 33:523–544CrossRef
19.
go back to reference Ludwig H (2002) Anemia of hematologic malignancies: what are the treatment options? Semin Oncol 29:45–54CrossRef Ludwig H (2002) Anemia of hematologic malignancies: what are the treatment options? Semin Oncol 29:45–54CrossRef
20.
go back to reference Yilmaz M, Atilla FD, Sahin F, Saydam G (2020) The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy. Support Care Cancer 28:1441–1448CrossRef Yilmaz M, Atilla FD, Sahin F, Saydam G (2020) The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy. Support Care Cancer 28:1441–1448CrossRef
21.
go back to reference Koizumi K, Tayama J, Ishioka T, Nakamura-Thomas H, Suzuki M, Hara M, Makita S, Hamaguchi T (2018) Anxiety, fatigue, and attentional bias toward threat in patients with hematopoietic tumors. PLoS One 13:e0192056CrossRef Koizumi K, Tayama J, Ishioka T, Nakamura-Thomas H, Suzuki M, Hara M, Makita S, Hamaguchi T (2018) Anxiety, fatigue, and attentional bias toward threat in patients with hematopoietic tumors. PLoS One 13:e0192056CrossRef
22.
go back to reference Jordan K, Aapro M, Kaasa S et al (2018) European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol 29:36–43CrossRef Jordan K, Aapro M, Kaasa S et al (2018) European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol 29:36–43CrossRef
23.
go back to reference El-Jawahri A, LeBlanc T, VanDusen H et al (2016) Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 316:2094–2103CrossRef El-Jawahri A, LeBlanc T, VanDusen H et al (2016) Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 316:2094–2103CrossRef
24.
go back to reference Porta-Sales J, Guerrero-Torrelles M, Moreno-Alonso D, Sarra-Escarre J, Clapes-Puig V, Trelis-Navarro J, Sureda-Balari A, Fernandez De Sevilla-Ribosa A (2017) Is early palliative care feasible in patients with multiple myeloma? J Pain Symptom Manage 54:692–700CrossRef Porta-Sales J, Guerrero-Torrelles M, Moreno-Alonso D, Sarra-Escarre J, Clapes-Puig V, Trelis-Navarro J, Sureda-Balari A, Fernandez De Sevilla-Ribosa A (2017) Is early palliative care feasible in patients with multiple myeloma? J Pain Symptom Manage 54:692–700CrossRef
25.
go back to reference Epstein AS, Goldberg GR, Meier DE (2012) Palliative care and hematologic oncology: the promise of collaboration. Blood Rev 26:233–239CrossRef Epstein AS, Goldberg GR, Meier DE (2012) Palliative care and hematologic oncology: the promise of collaboration. Blood Rev 26:233–239CrossRef
26.
go back to reference Smith TJ, Temin S, Alesi ER et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887CrossRef Smith TJ, Temin S, Alesi ER et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887CrossRef
27.
go back to reference El-Jawahri AR, Abel GA, Steensma DP et al (2015) Health care utilization and end-of-life care for older patients with acute myeloid leukemia. Cancer 121:2840–2848CrossRef El-Jawahri AR, Abel GA, Steensma DP et al (2015) Health care utilization and end-of-life care for older patients with acute myeloid leukemia. Cancer 121:2840–2848CrossRef
28.
go back to reference Temel JS, Greer JA, El-Jawahri A et al (2017) Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol 35:834–841CrossRef Temel JS, Greer JA, El-Jawahri A et al (2017) Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol 35:834–841CrossRef
29.
go back to reference Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742CrossRef Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742CrossRef
30.
go back to reference Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J, Bruera E (2014) Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer 120:1572–1578CrossRef Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J, Bruera E (2014) Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer 120:1572–1578CrossRef
31.
go back to reference Hui D, Park M, Liu D, Reddy A, Dalal S, Bruera E (2015) Attitudes and beliefs toward supportive and palliative care referral among hematologic and solid tumor oncology specialists. Oncologist 20:1326–1332CrossRef Hui D, Park M, Liu D, Reddy A, Dalal S, Bruera E (2015) Attitudes and beliefs toward supportive and palliative care referral among hematologic and solid tumor oncology specialists. Oncologist 20:1326–1332CrossRef
32.
go back to reference Hui D, Cerana MA, Park M, Hess K, Bruera E (2016) Impact of oncologists’ attitudes toward end-of-life care on patients’ access to palliative care. Oncologist 21:1149–1155CrossRef Hui D, Cerana MA, Park M, Hess K, Bruera E (2016) Impact of oncologists’ attitudes toward end-of-life care on patients’ access to palliative care. Oncologist 21:1149–1155CrossRef
33.
go back to reference Ruiz M, Reynolds P, Marranzini R, Khan A, Ketterer J, Brahim A (2018) Role of early palliative care interventions in hematological malignancies and bone marrow transplant patients: barriers and potential solutions. Am J Hosp Palliat Care 35:1456–1460CrossRef Ruiz M, Reynolds P, Marranzini R, Khan A, Ketterer J, Brahim A (2018) Role of early palliative care interventions in hematological malignancies and bone marrow transplant patients: barriers and potential solutions. Am J Hosp Palliat Care 35:1456–1460CrossRef
34.
go back to reference LeBlanc TW, O’Donnell JD, Crowley-Matoka M, Currow DC, Abernethy AP (2015) Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. J Oncol Pract 11:e230–e238CrossRef LeBlanc TW, O’Donnell JD, Crowley-Matoka M, Currow DC, Abernethy AP (2015) Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. J Oncol Pract 11:e230–e238CrossRef
35.
go back to reference Barni S, Maltoni M, Tuveri G et al (2011) Attitude of Italian medical oncologists toward palliative care for patients with advanced cancer: results of the SIO project. Support Care Cancer 19:381–389CrossRef Barni S, Maltoni M, Tuveri G et al (2011) Attitude of Italian medical oncologists toward palliative care for patients with advanced cancer: results of the SIO project. Support Care Cancer 19:381–389CrossRef
36.
go back to reference Cherny RI, Catane R, European Society of Medical Oncology Taskforce on Palliative and Supportive Care (2003) Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survery by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care. Cancer 98:2502–2510CrossRef Cherny RI, Catane R, European Society of Medical Oncology Taskforce on Palliative and Supportive Care (2003) Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survery by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care. Cancer 98:2502–2510CrossRef
37.
go back to reference Lesnock JL, Arnold RM, Meyn LA, Buss MK, Quimper M, Krivak TC, Edwards RP, Chang JC (2013) Palliative care education in gynecologic oncology: a survey of the fellows. Gynecol Oncol 130:431–435CrossRef Lesnock JL, Arnold RM, Meyn LA, Buss MK, Quimper M, Krivak TC, Edwards RP, Chang JC (2013) Palliative care education in gynecologic oncology: a survey of the fellows. Gynecol Oncol 130:431–435CrossRef
38.
go back to reference Buss MK, Lessen DS, Sullivan AM, Von Roenn J, Arnold RM, Block SD (2011) Hematology/oncology fellows’ training in palliative care: results of a national survey. Cancer 117:4304–4311CrossRef Buss MK, Lessen DS, Sullivan AM, Von Roenn J, Arnold RM, Block SD (2011) Hematology/oncology fellows’ training in palliative care: results of a national survey. Cancer 117:4304–4311CrossRef
39.
go back to reference Feld E, Singhi EK, Phillips S, Huang LC, Shyr Y, Horn L (2019) Palliative care referrals for advanced non-small-cell lung cancer (NSCLC): patient and provider attitudes and practices. Clin Lung Cancer 20:e291–e298CrossRef Feld E, Singhi EK, Phillips S, Huang LC, Shyr Y, Horn L (2019) Palliative care referrals for advanced non-small-cell lung cancer (NSCLC): patient and provider attitudes and practices. Clin Lung Cancer 20:e291–e298CrossRef
40.
go back to reference Hui D, De La Rosa A, Chen J, Dibaj S, Delgado Guay M, Heung Y, Liu D, Bruera E (2020) State of palliative care services at US cancer centers: an updated national survey. Cancer 126:2013–2023CrossRef Hui D, De La Rosa A, Chen J, Dibaj S, Delgado Guay M, Heung Y, Liu D, Bruera E (2020) State of palliative care services at US cancer centers: an updated national survey. Cancer 126:2013–2023CrossRef
41.
go back to reference Zafar SY, Currow DC, Cherny N, Strasser F, Fowler R, Abernethy AP (2012) Consensus-based standards for best supportive care in clinical trials in advanced cancer. Lancet Oncol 13:e77–e82CrossRef Zafar SY, Currow DC, Cherny N, Strasser F, Fowler R, Abernethy AP (2012) Consensus-based standards for best supportive care in clinical trials in advanced cancer. Lancet Oncol 13:e77–e82CrossRef
Metadata
Title
Recommendations for supportive care and best supportive care in NCCN clinical practice guidelines for treatment of cancer: Differences between solid tumor and hematologic malignancy guidelines
Authors
Li Mo
Diana L. Urbauer
Eduardo Bruera
David Hui
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06245-2

Other articles of this Issue 12/2021

Supportive Care in Cancer 12/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine